Payer+Provider's Health System Review
Gantenerumab’s Phase 3 Flop Means Lecanemab Emerges As Favorite In Antibody Class Targeting Amyloid Plaque In Alzheimer’s Patients
Medicare Plan Finder Likely Won’t Note New $35 Cap on Out-of-Pocket Insulin Costs
November 15, 2022
Twenty thousand children will be screened for type one diabetes in a landmark study that could lead to a national scheme.
Read the full post on Forbes - Healthcare